XML 85 R62.htm IDEA: XBRL DOCUMENT v3.24.3
Acquisitions and Divestitures (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended 9 Months Ended
Oct. 08, 2024
Jul. 11, 2024
Jun. 20, 2024
May 31, 2024
Sep. 29, 2024
Jun. 30, 2024
Sep. 29, 2024
Oct. 01, 2023
Dec. 31, 2023
Business Acquisition [Line Items]                  
Payments to acquire businesses             $ 15,145 $ 0  
Goodwill, related to acquisitions             8,187    
Contingent consideration         $ 1,222   1,222   $ 1,092
Proceeds from sale of business         300 $ 200      
Yellow Jersey Therapeutics                  
Business Acquisition [Line Items]                  
Asset acquisition, consideration transferred   $ 1,250              
Acquired in-process research and development   $ 1,250              
V-Wave Ltd. | Subsequent Event                  
Business Acquisition [Line Items]                  
Asset acquisition, consideration transferred $ 600                
Acquired in-process research and development 600                
Maximum | V-Wave Ltd. | Subsequent Event                  
Business Acquisition [Line Items]                  
Asset acquisition, consideration transferred $ 1,100                
Proteologix                  
Business Acquisition [Line Items]                  
Payments to acquire businesses     $ 800            
Assets acquired     1,200            
IPR&D     900            
Goodwill, related to acquisitions     300            
Liabilities assumed     300            
Contingent consideration     $ 100            
Discount rate     16.00%            
Acquisition related costs         0        
Proteologix | Minimum                  
Business Acquisition [Line Items]                  
Probability of success factor     30.00%            
Proteologix | Maximum                  
Business Acquisition [Line Items]                  
Probability of success factor     45.00%            
Shockwave Medical, Inc.                  
Business Acquisition [Line Items]                  
Assets acquired       $ 15,500 15,500   15,500    
IPR&D       600 600   600    
Liabilities assumed       $ 2,900 2,900   2,900    
Discount rate       9.00%          
Acquisition related costs         200   700    
Acquisition related costs, equity awards             400    
Share price (in dollars per share)       $ 335.00          
Consideration transferred       $ 200          
Weighted average useful life       14 years          
Deferred taxes       $ 1,500 1,500   1,500    
Shockwave Medical, Inc. | Minimum                  
Business Acquisition [Line Items]                  
Probability of success factor       50.00%          
Ambrx                  
Business Acquisition [Line Items]                  
Payments to acquire businesses         1,800        
Assets acquired         2,300   2,300    
IPR&D         1,900   1,900    
Goodwill, related to acquisitions             300    
Liabilities assumed         $ 500   $ 500    
Discount rate         17.00%   17.00%    
Share price (in dollars per share)         $ 28.00   $ 28.00    
Consideration transferred         $ 2,000        
Deferred taxes         $ 400   $ 400    
Ambrx | Minimum                  
Business Acquisition [Line Items]                  
Probability of success factor         40.00%   40.00%    
Ambrx | Maximum                  
Business Acquisition [Line Items]                  
Probability of success factor         70.00%   70.00%